Stock Earnings
Analysts review TG Therapeutics Inc’s rating
TG Therapeutics Inc’s filing revealed that its Director Echelard Yann acquired Company’s shares for reported $0.49 million on Nov 05
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.